-- Post hoc analysis of UPLIZNA Phase 2/3 trial shows all seven patients who had attacks while receiving rituximab were attack-free after switching to UPLIZNA -- UPLIZNA is the first and only ...

Researchers report that myelin breakdown results in an accumulation of very long-chain fatty acids (VLCFA) and their intermediates, which triggers an autoimmune response that damages brain cells.

"In terms of association with climate, our results suggest a relationship between enhancing lesions and tropical nights, a variable indicating extreme temperatures, which had not been previously ...

—Evidence from a recent study found that improvement in depression symptoms was associated with a reduction in physical, cognitive, and social fatigue in patients with multiple sclerosis. As ...

According to a 2019 study funded by the National Multiple Sclerosis Society, almost 1 million people in the US have received a diagnosis of the disorder. MS is a chronic neurological disorder where ...

Some MS diets may help lower inflammation marker levels, but evidence from clinical trials remains limited, according to a new review paper.

Criteria used by neurologists to assess for multiple sclerosis (MS) in adults may fail to identify the illness in children with imaging suspicious for the disease, an oversight that could delay ...

Managing multiple sclerosis (MS) is not a straight path. From getting diagnosed to treating symptoms, it’s a journey of ups and downs. Nearly one million people in the United States have MS and ...

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Multiple sclerosis (MS) is a disease of the ...